Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Patient Experiences of Use of Point-of-Care Ultrasound in General Practice

11 dicembre 2018 aggiornato da: Camilla Aakjær Andersen, Aalborg University

Patient Experiences of Use of Point-of-Care Ultrasound in General Practice: A Questionnaire Study

This study in part of a larger cohort study (clinical trials ID number: NCT03375333) that examine the use of ultrasound in general practice.

In the present study patient experiences, with use of ultrasound in the consultation at the general practitioners office, will be explored through a questionnaire.

Panoramica dello studio

Stato

Completato

Descrizione dettagliata

This study is a Cross-sectional study, which is conducted as part of a larger cohort study: How Point-of-Care Ultrasound (POC-US) Affects the Diagnostic Process in General Practice. A prospective follow-up study. (Clinical trials registration number: NCT03375333)

Study setting:

The study will take place in 20 different general practices in Denmark where the general practitioners (GPs) use POC-US.

Interventions There is no intervention in this study. The registration in this study will reflect GPs routine daily use of POC-US not adding more examinations or in other ways influence on the treatment of patients.

Sample size Twenty general practitioners (GPs) are expected to use POC-US 2-3 times a day, and assuming a participation rate of 80%, there will be between 640-960 US scan during the study period of one month.

Recruitment All patients who consult the participating GP for conditions relevant for a POC-US examination will be offered to participate in the study. Patients are excluded if they do not wish to participate or if they are not able to give an informed consent.

Patients must provide written, informed consent before any study procedures occur. Only patients assigned to the GPs practice can participate in the study.

Data collection method After the consultation in the GP's office, patients will be asked to fill out a questionnaire about their experience with POC-US in the consultation. The GPs will provide the patients with a unique ID-number and a link to an online questionnaire on the SurveyXact server. The patients will access the online questionnaire using this ID-number through Ipads or on a paper edition.

Baseline information regarding the participating GPs will be provided through the original study. Baseline questions about the patients will be part of the patient-questionnaire following the consultation.

The items in this questionnaire are generated from a qualitative interview study with GPs working in general practice and using POC-US. The items are the GPs expressed believes and concerns about how ultrasound was experienced by their patients.

This questionnaire is developed through the following steps:

  1. A first edition of the questionnaire is developed based on the results of a qualitative interview study with Danish GPs on their experiences on how ultrasound can be used in general practice.
  2. To test face validity, comprehension and wording of the questionnaire, pilot tests are done with laypeople and patients,using the "think-aloud" technique and cognitive interviewing. The pilot-tests are done in two geographical-separated clinics including five patients in each clinic. Adaptions and rephrasing follow after the results are compared.
  3. A validation test will include presenting the rephrased questions from the pilot-tests to 5 GPs, who use ultrasound, and asking them to compare the phrased questions to the original items from the qualitative interviews. Adaptions will follow.
  4. A final pilot-test will include interviews with patients, who have been ultrasound scanned in two other clinics using the "Think-aloud" technique. In this pilot-test the patients are presented to both a paper-version and an online-version of the questionnaire, to test functionality and feasibility. Pilot-tests and adaptions will continue until the questionnaire is completed without difficulties.

Retention Participant Retention GPs will be asked to register not-included patients, in whom POC-US was used during the study period, on a separate form and to declare the reason for the failed inclusion of the patient.

Participant Withdrawal Participating GPs and patients may withdraw from the study for any reason at any time.

Data management Data will be saved electronically in the SurveyXact server and on a server at Aalborg University and will only be accessed by the research group using passwords.

The Research Unit for General Practice in Aalborg is the Data Controller. Each participating GP will be data processor and can only process data pursuant to an agreement with the data controller. A data processor agreements will be made between the Research Unit for General Practice in Aalborg and each participating GP, between the Research Unit for General Practice in Aalborg and Aalborg University, and between Aalborg University and SurveyXact according to the Danish Data Protection Agency recommendations.

The Key files identifying the patients will be safely stored at the GPs office and the research group will not have access to this information during the study.

Statistics The questionnaire data will be collected on an ordinal scale and reported descriptively using frequencies. The correlation between the GPs reported confidence in the tentative diagnosis on a numeric rating scale from 1-5 perceived at an ordinal scale and patients reported experience of ultrasound in the consultation will be compared using scatterplots and Goodman and Kruskal's gamma will be used to test association.

Data monitoring During the study period the research team will be able to observe if the GPs include patients in the study and make contact to the GPs who fail to include patients in order to help out with any difficulties.

Harms All adverse events occurring during the study will be registered.

Research ethics approval The studies are approved by the Danish Data Protection Agency and the Committee of Multipractice Studies in General Practice in Denmark.

Consent or assent Prior to participation, patients will receive written and oral information and a written consent to participate will be obtained.

If a GP or a patient wished to redraw their consent to participate in the study, the GP will contact the research team and no further data will be collected.

Protocol amendments Will be declared and all editions and changes in the protocol will be saved.

Confidentiality All participating GPs have signed a confidentiality agreement.

Declaration of interest None

Access to data Only the Research team will have access to data.

Tipo di studio

Osservativo

Iscrizione (Effettivo)

579

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

      • Aalborg, Danimarca, 9220
        • Research unit for general practice in Aalborg,department of clinical medicine Aalborg university

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Bambino
  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

The study will take place in 20 different general practices in Denmark where the GPs use POC-US. The participating GPs will try to include all patients were they use POC-US in the consultation.

Patients must provide written, informed consent before any study procedures occur (see Appendix 1 for sample Informed Consent Form). Only patients assigned to the GPs practice can participate in the study.

Descrizione

Inclusion criteria:

- All patients, who the GP intends to examine with POC-US.

Exclusions criteria:

  • Patient not willing or able to give informed consent
  • Patients previously included in the study

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Modelli osservazionali: Coorte
  • Prospettive temporali: Trasversale

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Information
Lasso di tempo: assessed immediately after the ultrasound examination

This domain will be explored through the following questions:

Were you informed about the purpose of the ultrasound examination? Were you informed about the difference between a specialist ultrasound and a GP ultrasound? Were you informed about the result of the ultrasound examination?

assessed immediately after the ultrasound examination
Influence on the consultation
Lasso di tempo: assessed immediately after the ultrasound examination

This domain will be explored through the following questions:

Did you think the ultrasound examination was a natural part of the consultation? Did you think the ultrasound examination was disruptive in the consultation? Did the ultrasound examination influence the relationship between the GP and you? Do you think ultrasound made a difference in the consultation?

assessed immediately after the ultrasound examination
Diagnostic reassurance
Lasso di tempo: assessed immediately after the ultrasound examination

This domain will be explored through the following questions:

Do you feel more thoroughly examined after the ultrasound examination? Do you have a better understanding of your health problem after the ultrasound examination? Do you feel more at ease after the ultrasound examination? Has your confidence in the GPs diagnosis changed after the ultrasound examination? Has the ultrasound examination changed your feeling of being taken seriously?

assessed immediately after the ultrasound examination
Patient satisfaction
Lasso di tempo: assessed immediately after the ultrasound examination

This domain will be explored through the following questions:

Was your overall experience with ultrasound in the GP's office positive or negative? Would you recommend ultrasound in the GPs office to others? Do you think ultrasound is a service improvement in the GP's office? Do you think ultrasound is a quality improvement in the GP's office?

assessed immediately after the ultrasound examination

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Associations between GP confidence in the diagnosis and patients sense of diagnostic reassurance
Lasso di tempo: assessed immediately after the ultrasound examination
Association between GPs declared confidence in the tentative diagnosis after using ultrasound in the consultation (data from the original cohort expressed on a scale from increased confidence to decreased confidence) and patients' answers to the question "Has your confidence in the GPs diagnosis changed after the ultrasound examination?" expressed on a scale from decreased to increased confidence.
assessed immediately after the ultrasound examination
Associations between GP confidence in the diagnosis and patients experience of improved care
Lasso di tempo: assessed immediately after the ultrasound examination
Association between GPs declared confidence in the tentative diagnosis after using ultrasound in the consultation (expressed in the original cohort on a scale from increased confidence to decreased confidence) and patients' answers to the question "Do you feel more at ease after the ultrasound examination?" expressed on a scale from less at ease to more at ease.
assessed immediately after the ultrasound examination

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Cattedra di studio: Martin Bach Jensen, Professor, GP, PhD, Aalborg University

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

15 gennaio 2018

Completamento primario (Effettivo)

1 settembre 2018

Completamento dello studio (Effettivo)

2 settembre 2018

Date di iscrizione allo studio

Primo inviato

10 gennaio 2018

Primo inviato che soddisfa i criteri di controllo qualità

29 gennaio 2018

Primo Inserito (Effettivo)

31 gennaio 2018

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

12 dicembre 2018

Ultimo aggiornamento inviato che soddisfa i criteri QC

11 dicembre 2018

Ultimo verificato

1 dicembre 2018

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • GULD-patient questionnaire

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

Indeciso

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi